Amyloid-beta clearance
AssigneeGwangju Institute of Science and Technology
InventorsWoo Jin Park, Hye-eun Han
Life of this patent
Estimating the term…
Abstract
The present invention relates to a pharmaceutical composition for preventing or treating an amyloid β-caused disease, which comprises as an active ingredient a NIa (nuclear inclusion a) protease or a gene carrier containing a nucleotide sequence encoding the NIa protease. The pharmaceutical composition of this invention is very effective to treat a variety of diseases or disorders, inter alia, Alzheimer's disease.
Claims12
1-11. (canceled)
A method for preventing or treating an amyloid β-caused disease, which comprises administering to a mammalian subject a pharmaceutical composition comprising as an active ingredient a NIa (nuclear inclusion a) protease or a gene carrier containing a nucleotide sequence encoding the NIa protease.
Dependencies are inferred from the claim text.